BURGESS A W ET AL: "An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors", MOLECULAR CELL, CELL PRESS, CAMBRIDGE, MA, US, vol. 12, no. 3, 1 September 2003 (2003-09-01), pages 541-552, XP002396190, ISSN: 1097-2765, DOI: 10.1016/S1097-2765(03)00350-2 (B1)

CHO HYUN-SOO ET AL: "Structure of the extracellular region of HER3 reveals an interdomain tether", SCIENCE (WASHINGTON D C), vol. 297, no. 5585, 23 August 2002 (2002-08-23), pages 1330-1333, XP002662196, ISSN: 0036-8075 (B1)

FRANKLIN M C ET AL: "Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex", CANCER CELL, CELL PRESS, US, vol. 5, no. 4, 1 April 2004 (2004-04-01), pages 317-328, XP002372929, ISSN: 1535-6108, DOI: 10.1016/S1535-6108(04)00083-2 (B1)

WO-A2-2008/019290 (B1)

MCKAY BROWN ET AL: "Tolerance to single, but not multiple, amino acid replacements in antibody V-H CDR2: A means of minimizing B cell wastage from somatic hypermutation?", JOURNAL OF IMMUNOLOGY, AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 156, no. 9, 1 January 1996 (1996-01-01), pages 3285-3291, XP002649029, ISSN: 0022-1767 (B1)

WO-A2-2006/087637 (B1)

WO-A2-2007/077028 (B1)

KANI KIAN ET AL: "The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformation", BIOCHEMISTRY, vol. 44, no. 48, December 2005 (2005-12), pages 15842-15857, XP002662197, ISSN: 0006-2960 (B1)